Table 3.
Pathway enrichment analysis revealed 11 significantly enriched pathways.
| Term ID | Description | P-value (uncorrected) | P-value (corrected) |
|---|---|---|---|
| hsa05170 | Human immunodeficiency virus 1 infection | < 0.001 | 0.203 |
| hsa04218 | Cellular senescence | 0.009 | 0.641 |
| hsa05145 | Toxoplasmosis | 0.015 | 0.754 |
| hsa05014 | Amyotrophic lateral sclerosis | 0.036 | 1.000 |
| hsa04115 | p53 signaling pathway | 0.001 | 0.209 |
| hsa04114 | Oocyte meiosis | 0.005 | 0.524 |
| hsa04151 | PI3K-Akt signaling pathway | 0.009 | 0.641 |
| hsa05202 | Transcriptional misregulation in cancer | 0.013 | 0.747 |
| hsa04610 | Complement and coagulation cascades | 0.018 | 0.770 |
| hsa04936 | Alcoholic liver disease | 0.029 | 1.000 |
| hsa04010 | MAPK signaling pathway | 0.045 | 1.000 |
They are grouped into five clusters based on membership similarities. PI3K-Akt, phosphoinositide-3-kinase–protein kinase B/Akt; MAPK, mitogen-activated protein kinase.